Pulmonary LELC had better prognosis, and previous studies also have discovered that classic lung cancer oncogenic drivers including KRAS, EGFR, BRAF, ALK, and ROS1 were limitedly involved in tumorigenesis and progression of pulmonary LELC (8, 17). Here, ROS1 is linked to lung cancer.